GO
Loading...

Enter multiple symbols separated by commas

White House Government Agencies

More

  • April 15- Texas- based Internet provider Alamo Broadband Inc filed a lawsuit on Wednesday asking the federal appeals court based in New Orleans to block new web traffic regulations from the Federal Communications Commission.

  • April 15- U.S. health regulators on Wednesday approved Amgen Inc's Corlanor to treat patients with chronic heart failure, giving the world's largest biotechnology company its first cardiovascular product. RBC Capital Markets analyst Michael Yee said that long term Corlanor could become a $500 million a year drug for Amgen. Amgen shares rose 1.3 percent in...

  • April 15- The Medicines Co's intravenous blood clot preventer can be used in angioplasty procedures, an independent advisory panel to the U.S. Food and Drug Administration said on Wednesday. The recommendation follows a review published by FDA staff on Monday, which supported the approval of the drug. Cangrelor, which won European approval in March, was...

  • Google reached a settlement in 2013 with the U.S. Federal Trade Commission over Web search allegations. However, regulators often speak with companies about fairness complaints without the discussions leading to an investigation, and Google has already successfully fought off a U.S. civil suit involving Android. The meetings between Google critics and...

  • MIAMI, April 15- A group of South Florida mayors are escalating their campaign against plans to expand a nuclear power plant near Miami that involves constructing 100- foot tall transmissions lines through some of the area's toniest neighborhoods. Florida Power& Light Co is seeking federal approval from the Nuclear Regulatory Commission to add nuclear...

  • April 15- The Medicines Co's intravenous blood clot preventer can be used in angioplasty procedures, an independent advisory panel to the U.S. Food and Drug Administration said on Wednesday. The panel voted 7-2 to support the approval of the injection, cangrelor, for use in certain patients undergoing angioplasty, a procedure to widen narrowed or clogged...

  • NEW YORK, April 15- U.S. That has at the margin supported the Treasury market, "said Dan Mulholland, head of Treasuries trading at Credit Agricole in New York. New York Federal Reserve data also showed that growth in manufacturing activity in New York state unexpectedly contracted in April, weakening for a third straight month as the pace of new orders fell to a...

  • NEW YORK, April 15- U.S. That has at the margin supported the Treasury market this morning, "said Dan Mulholland, head of Treasuries trading at Credit Agricole in New York. New York Federal Reserve data earlier showed that growth in manufacturing activity in New York state also unexpectedly contracted in April, weakening for a third straight month as the pace of new...

  • DIARY- Top Economic Events to April 24 Tuesday, 14 Apr 2015 | 8:01 PM ET

    WASHINGTON- Federal Reserve issues the Beige Book of economic condition- 1800 GMT. WASHINGTON- Levy Economics Institute of Bard College holds 24th Annual Hyman P. Minsky Conference on the State of the U.S. and World Economies in Washington. WASHINGTON- Federal Reserve Bank of St. Louis President James Bullard gives presentation on the U.S. economy and monetary...

  • WINONA, Minn., April 14- Raising interest rates this year, as most Federal Reserve officials expect, would be "inappropriate" because it would delay the return of too-low inflation to the U.S. central bank's 2 percent goal, a top Fed official said on Tuesday. A rate hike would also work against the Fed's other goal of full employment, Narayana Kocherlakota, president of...

  • NEW YORK, April 14- AT&T Inc and three cable and wireless trade groups filed separate lawsuits on Tuesday challenging the U.S. Federal Communications Commission over its new web traffic regulations. The suit comes even as the No.2 U.S wireless company's proposed $48.5 billion acquisition of satellite TV operator DirecTV is under FCC review.

  • WASHINGTON, April 14- AstraZeneca Plc's diabetes drug Onglyza and Takeda Pharmaceutical Co.' s rival product Nesina should carry information about the risk of heart failure, an advisory committee to the U.S. Food and Drug Administration said on Tuesday. The panel reviewed safety data on AstraZeneca's Onglyza and Takeda's Nesina. The studies were requested by...

  • April 14- An advisory panel to the U.S. Food and Drug Administration voted 13-3 that Takeda Pharmaceutical's diabetes drug Nesina should contain information about a potential increased risk of heart failure. The panel voted 16-0 that the drug has an acceptable overall cardiovascular safety profile, with no significant increased risk of major heart events...

  • The FDA issued the guidelines to help clarify what changes require regulatory approval under the 2009 Tobacco Control Act. The guidelines go far beyond that authority, the plaintiffs said, by requiring FDA authorization to make any labeling changes that would render a product already on the market "distinct," like a name change. Although the FDA has framed the...

  • A preliminary FDA review of Nesina, or alogliptin, showed a numerical increase in heart failure hospitalizations but not a statistically significant increase. Even so, some analysts expect the FDA to treat all drugs in the class the same way. "We believe the FDA will likely view the risk as likely to be a class effect and apply changes to all approved drugs in the...

  • WASHINGTON, April 14- AstraZeneca Plc's diabetes drug Onglyza should include new safety information about the risk of heart failure, a U.S. Food and Drug Administration advisory panel concluded on Tuesday. The FDA is not obliged to follow the advice of its advisory panels but typically does so. A preliminary FDA review of the drug published on Friday noted an...

  • WASHINGTON, April 14- AstraZeneca Plc's diabetes drug Onglyza should include new safety information about the risk of heart failure, an advisory panel to the U.S. Food and Drug Administration concluded on Tuesday. The panel voted overwhelmingly that the drug's label should be changed to add information about an increased heart failure risk, but did not...

  • WASHINGTON, April 14- U.S. producer prices rose in March after four straight months of declines and there were signs of some firming in underlying inflation, which should keep the Federal Reserve on course to start raising interest rates this year. The Labor Department said on Tuesday its producer price index for final demand increased 0.2 percent last month,...

  • DIARY- Top Economic Events to April 23 Monday, 13 Apr 2015 | 8:01 PM ET

    STOCKHOLM- Sweden's Riksbank Deputy Governor Cecilia Skingsley will participate in a seminar on pay formation that promotes the competitiveness of the manufacturing industry- 1135 GMT. WASHINGTON- Federal Reserve issues the Beige Book of economic condition- 1800 GMT. WASHINGTON- Levy Economics Institute of Bard College holds 24th Annual Hyman P. Minsky...

  • SAN FRANCISCO, April 13- Federal Reserve policymakers should not read too much into financial market prices to glean the views of investors on interest rates or inflation because prices are hard to decipher, according to research released Monday by the San Francisco Fed. "Fluctuations in risk and liquidity premiums and in other market forces complicate how...